91.4%
2022 (latest)
MMR ≥1 DOSE BY 24 MONTHS
percent · 2011–2022 · higher is better · CDC NIS-Child (ChildVaxView), National Immunization Survey
90.1%
2011
92.3%
high · 2018
89.8%
low · 2014
+1.3 pts
since 2011
by age 24 months, by birth yearat 19–35 months, by survey yeartwo NIS-Child instruments, side by side, never spliced
┊ dashed lines mark 2020 COVID-19 pandemic
Method & caveats. CDC NIS-Child share receiving at least one MMR dose by age 24 months. Cohort is the birth year (children by age 24 months, by birth year). This is a paired comparison with the survey-year 19–35-month series, not a continuation of it.
Sources
Every value on this page is read from the publisher below. Current and historical source documents:
- https://data.cdc.gov/resource/fhky-rtsk.json
- https://github.com/danielmiessler/substrate/tree/main/Data/US-Disease-And-Vaccination
Data
| Year | MMR ≥1 dose by 24 months | MMR ≥1 dose, children 19–35 months | Change |
|---|---|---|---|
| 2022 | 91.4% | — | +1.2 pts |
| 2021 | 90.2% | — | +0.0 pts |
| 2020 | 90.2% | — | −1.3 pts |
| 2019 | 91.5% | — | −0.8 pts |
| 2018 | 92.3% | — | +1.9 pts |
| 2017 | 90.4% | 91.5% | −0.4 pts |
| 2016 | 90.8% | 91.1% | +0.0 pts |
| 2015 | 90.8% | 91.9% | +1.0 pts |
| 2014 | 89.8% | 91.5% | −0.5 pts |
| 2013 | 90.3% | 91.9% | −0.3 pts |
| 2012 | 90.6% | 90.8% | +0.5 pts |
| 2011 | 90.1% | 91.6% | — |
Also in Disease & Vaccination